| Aug 13 |
UroGen Pharma Ltd. (URGN) Q2 2024 Earnings Call Transcript
|
| Aug 13 |
Urogen Pharma (URGN) Reports Q2 Loss, Misses Revenue Estimates
|
| Aug 13 |
UroGen Pharma misses top-line and bottom-line estimates; lowers FY24 outlook
|
| Aug 13 |
UroGen Pharma Ahead of Schedule to Complete UGN-102 NDA Submission and Reports 2024 Second Quarter Financial Results and Business Highlights
|
| Aug 7 |
Earnings Preview: Precigen, Inc. (PGEN) Q2 Earnings Expected to Decline
|
| Aug 5 |
UroGen Pharma to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024
|
| Aug 2 |
Does Urogen Pharma (URGN) Have the Potential to Rally 171.05% as Wall Street Analysts Expect?
|
| Aug 1 |
Urogen Pharma (URGN) Expected to Beat Earnings Estimates: Should You Buy?
|
| Jul 17 |
Wall Street Analysts See a 149.01% Upside in Urogen Pharma (URGN): Can the Stock Really Move This High?
|
| Jun 27 |
UroGen Pharma Stock Earns 91 RS Rating
|
